Abstract
The in vitro activities of LY146032 and seven comparative antimicrobial agents against 14 species of staphylococci, streptococci, and enterococci were studied. MICs of LY146032 were less than or equal to 0.5 microgram/ml for all staphylococci, including oxacillin-resistant strains; less than or equal to 0.25 microgram/ml for all streptococci (except viridans group streptococci); and less than or equal to 4 micrograms/ml for all viridans group streptococci and enterococci. MICs were minimally affected by variations in inoculum size, and LY146032 was bactericidal against all species tested.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference4 articles.
1. In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic;Eliopoulos G. M.;Antimicrob. Agents Chemother.,1985
2. National Committee for Clinical Laboratory Standards. 1985. Approved standard M7-A. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards Villanova Pa.
3. Method for reliable determination of minimal lethal antibiotic concentrations;Pearson R. D.;Antimicrob. Agents Chemother.,1980
4. Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci;Thornsberry C.;J. Clin. Microbiol.,1983
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献